{"mainPropery":{"diseaseId":7514,"diseaseName":"Pyruvate kinase deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7514/pyruvate-kinase-deficiency","synonyms":["Pyruvate kinase deficiency of red cells","Pyruvate kinase deficiency of erythrocytes","PK deficiency"],"synonyms-with-source":[{"name":"Pyruvate kinase deficiency of red cells"},{"name":"Pyruvate kinase deficiency of erythrocytes"},{"name":"PK deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"266200"},{"identifierType":"ORPHANET","identifierId":"766"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[{"resourceID":872,"resourceName":"European Network for Rare and Congenital Anaemias (ENERCA)","abbreviation":"","address1":"University of Barcelona","address2":"Red Cell Pathology Unit","address3":"C/Villarroel, 170 - 08036","address4":"Barcelona","address5":"","city":"","state":"","zip":"","country":"España","phone":"(34) 93 451 5950","tty":"","tollFree":"","fax":"(34) 93 227 1764","email":"enerca@enerca.org","url":"http://www.enerca.org","freeText":""},{"resourceID":3665,"resourceName":"Pyruvate Kinase Deficiency: Understanding and living with PKD","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"https://pyruvatekinasedeficiency.com/contact/","url":"https://pyruvatekinasedeficiency.com/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/266200' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=(%22pyruvate+kinase%22%5BMeSH+Terms%5D+OR+pyruvate+kinase%5BText+Word%5D)+AND+(%22deficiency%22%5BSubheading%5D+OR+deficiency%5BText+Word%5D)' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Pyruvate kinase deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/pyruvate-kinase-deficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Pyruvate kinase deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1251,"resourceId":1915,"resourceName":"Pyruvate Kinase Deficiency article","descriptionText":"Durand PM, Coetzer TL. <a href='http://www.haematologica.org/cgi/reprint/haematol.12450v1 ' target='_blank'>Pyruvate kinase deficiency protects against malaria in humans</a>. <em>Haematologica.</em> 2008 Jun;93(6):939-40. Epub 2008 May 6.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1849472' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/465/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001197.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/2196589-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=766' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1591,"resourceId":2206,"resourceName":"Facebook Groups","descriptionText":"Visit the <a href='https://www.facebook.com/groups/50217858779/' target='_blank'>People with Pyruvate Kinase Deficiency</a> group on Facebook.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:266200' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":708,"questionText":"What is pyruvate kinase deficiency?","answerText":"<span class=\"minusOne\"><strong>Pyruvate kinase deficiency</strong>&nbsp;is a genetic blood disorder characterized&nbsp;by low levels of an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">enzyme</a> called <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003357.htm\" target=\"_blank\">pyruvate kinase</a>, which is used by <a href=\"http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=46425\" target=\"_blank\">red blood cells</a>. Without pyruvate kinase, red blood cells break down too easily, resulting in low levels of these cells&nbsp;(<a href=\"http://www.nhlbi.nih.gov/health/dci/Diseases/ha/ha_whatis.html\" target=\"_blank\">hemolytic anemia</a>).[464] The signs and symptoms of the disease may vary greatly from person to person. However, they usually&nbsp;include&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003243.htm\" target=\"_blank\">jaundice</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003276.htm\" target=\"_blank\">enlargement of the spleen</a>, and </span><span class=\"minusOne\">mild or severe hemolysis (red cell breakdown), leading to&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/anemia.html\" target=\"_blank\">anemia</a>.[3929]\r\nIn some cases, the problems may first appear while in utero, causing a condition in which abnormal amounts of fluid build up in two or more body areas of the fetus (hydrops fetalis). Newborns may present with prolonged <a href=\"http://www.nlm.nih.gov/medlineplus/jaundice.html\" target=\"_blank\">jaundice</a> and anemia. Older children may be pale (due to anemia) and have intermittent episodes of jaundice. Mild cases may escape detection until adulthood.[464]&nbsp;Although the anemia tends&nbsp;to stabilize in adulthood, episodes of anemia may occur with acute infections, stress, and pregnancy.[10399] Pyruvate kinase deficiency is caused by a <a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/genemutation\" target=\"_blank\">mutation</a>&nbsp;in the&nbsp;<a href=\"http://ghr.nlm.nih.gov/gene/PKLR\" target=\"_blank\"><em>PKLR</em></a>&nbsp;gene&nbsp;and is inherited in an <a href=\"http://ghr.nlm.nih.gov/handbook/illustrations/autorecessive\" target=\"_blank\">autosomal recessive</a>&nbsp;fashion.[464][3928] Treatment remains supportive rather than curative.[10399]<br />\r\n<br />\r\n<br />\r\n<br />\r\n&nbsp;</span>","dateModified":"2016-01-13T00:00:00"},"basicQuestions":[{"questionId":1530,"questionText":"What are the signs and symptoms&nbsp;of pyruvate kinase deficiency?","answerText":"The signs and&nbsp;symptoms of pyruvate kinase deficiency may vary greatly from person to person, but usually include the breakdown of red blood cells resulting in <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000571.htm\" target=\"_blank\" tabindex=\"-1\">hemolytic anemia</a>, a yellowing of the whites of the eyes&nbsp;(icterus), fatigue, lethargy,&nbsp;recurrent <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000273.htm\" target=\"_blank\" tabindex=\"-1\">gallstones</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003243.htm\" target=\"_blank\" tabindex=\"-1\">jaundice</a>, and pale skin (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003244.htm\" target=\"_blank\" tabindex=\"-1\">pallor</a>).[464]&nbsp;<br />\r\n<br />\r\nIn more severe cases, the first signs and symptoms may appear in utero in the form of hydrops fetalis, a condition in which abnormal amounts of fluid build up in two or more body areas of the fetus.&nbsp;Newborns may present with prolonged jaundice and anemia. Older children may be pale (due to anemia) and have intermittent episodes of jaundice. Mild cases may escape detection until adulthood.[464] Although the anemia tends to stabilize in adulthood, episodes of anemia may occur with acute infections, stress, and pregnancy.[10399]","dateModified":"2016-01-13T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":464,"authors":"Haldeman-Englert C","articleTitle":"Pyruvate kinase deficiency","bookWebsiteJournalTitle":"MedlinePlus Encyclopedia","date":"2/3/2014","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001197.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10399,"authors":"Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B","articleTitle":"Erythrocyte pyruvate kinase deficiency: 2015 status report","bookWebsiteJournalTitle":"Am J Hematol","date":"2015 Sep","volume":"90(9)","pages":"825-30","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1466,"questionText":"What causes pyruvate kinase deficiency?","answerText":"In most cases, pyruvate kinase deficiency is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene/PKLR\" target=\"_blank\"><em>PKLR </em>gene</a>.[464] More than 100 different mutation in the <em>PKLR </em>gene have been detected. Medical conditions, such as acute <a href=\"http://www.mayoclinic.com/print/leukemia/DS00351/DSECTION=all&amp;METHOD=print\" target=\"_blank\">leukemia</a>, preleukemia <a href=\"http://www.aamds.org/diseases/mds\" target=\"_blank\">(myelodysplastic syndrome)</a>, and refractory <a href=\"http://www.irondisorders.org/Disorders/Sideroblastic.asp\" target=\"_blank\">sideroblastic anemia</a>,&nbsp;as well as&nbsp;complications from chemotherapy, can cause an acquired pyruvate kinase deficiency. This type is more common and milder than the hereditary type.[472]","dateModified":"2011-07-18T11:44:00","resourceClassificationName":"Cause","references":[{"referenceId":464,"authors":"Haldeman-Englert C","articleTitle":"Pyruvate kinase deficiency","bookWebsiteJournalTitle":"MedlinePlus Encyclopedia","date":"2/3/2014","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001197.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":472,"authors":"Hassan M Yaish, MD","articleTitle":"Pyruvate Kinase Deficiency","bookWebsiteJournalTitle":"Medscape","date":"April 28, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2196589-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":729,"questionText":"How is&nbsp;pyruvate kinase deficiency inherited?","answerText":"Pyruvate kinase deficiency is&nbsp;inherited in&nbsp;an <a href=\"http://ghr.nlm.nih.gov/handbook/illustrations/autorecessive\" target=_blank>autosomal recessive</a> fashion, which means that a child must&nbsp;inherit a <a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=_blank>gene</a> with a disease-causing <a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/genemutation\" target=_blank>mutation</a>&nbsp;from both parents to develop the disorder.&nbsp;The gene that causes pyruvate kinase deficiency is called the <a href=\"http://ghr.nlm.nih.gov/locuslink=5313\" target=_blank><em>PKLR</em></a> gene that is located on <a href=\"http://ghr.nlm.nih.gov/chromosome=1\" target=_blank>chromosome 1q21</a>.[3928]&nbsp;&nbsp;Although the inheritance is clinically autosomal recessive, most affected individuals are <a href=\"http://www.medterms.com/script/main/art.asp?articlekey=33675\" target=_blank>compound heterozygous</a> for&nbsp;two different mutant alleles. It is estimated that approximatly 1 in 100 people carry one copy of a&nbsp;disease-causing mutation in the&nbsp;<em>PKLR </em>gene.[472]&nbsp; <a href=\"http://www.genome.gov/glossary/?id=23\" target=_blank>Carriers</a> of&nbsp;one non-working PKLR gene usually have moderatly reduced levels of pyruvate kinase activity but do not develop clinical symptoms.&nbsp;It is possible that carriers of a mutant pyruvate kinase&nbsp;gene<sup> </sup>may have a protective advantage against malaria in areas where the disease is endemic.[905]</font><sup> </sup></font>","dateModified":"2011-07-18T11:43:00","resourceClassificationName":"Inheritance","references":[{"referenceId":472,"authors":"Hassan M Yaish, MD","articleTitle":"Pyruvate Kinase Deficiency","bookWebsiteJournalTitle":"Medscape","date":"April 28, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2196589-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":905,"authors":"Durand PM, Coetzer TL","articleTitle":"Pyruvate kinase deficiency protects against","bookWebsiteJournalTitle":"Haematologica","date":"June 2008","url":"http://www.haematologica.org/cgi/reprint/haematol.12450v1","dateAccessed":"2011-07-18T00:00:00"},{"referenceId":3928,"authors":"Zanella A, Fermo E, Bianchi P, Chiarelli LR, Valentini G","articleTitle":"Pyruvate kinase deficiency: the genotype-phenotype association.","bookWebsiteJournalTitle":"Blood Rev","date":"2007","url":"http://www.ncbi.nlm.nih.gov/pubmed/17360088","dateAccessed":"2011-07-18T00:00:00"}]},{"questionId":1642,"questionText":"Is genetic testing available for pyruvate kinase deficiency?","answerText":"Yes.&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/clinical_disease_id/2896?db=genetests\" target=_blank>GeneTests</a> lists laboratories offering clinical genetic testing for this condition. Clinical genetic tests are ordered to help diagnose an affected&nbsp;person or other family members&nbsp;and to aid in decisions regarding medical care or reproductive issues. We recommend that you talk to your health care provider or a genetic professional to learn more about your testing options.","dateModified":"2011-07-18T11:29:00","resourceClassificationName":"Diagnosis","references":[]},{"questionId":717,"questionText":"How might&nbsp;pyruvate kinase deficiency be treated?","answerText":"Mild cases require no treatment. People with severe anemia may need&nbsp;blood transfusions.&nbsp;&nbsp;In newborns with dangerous levels of jaundice, a health care provider may recommend an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002923.htm\" target=\"_blank\">exchange transfusion</a>. Surgical removal of the spleen (splenectomy) may also be necessary to help reduce the destruction of red blood cells. However, this does not help in all cases. With small children, this is delayed as long as possible to allow the immune system to mature. Other treatment is symptomatic and supportive. Someone who had a splenectomy should receive the <a href=\"https://medlineplus.gov/ency/imagepages/9767.htm\" target=\"_blank\">pneumococcal vaccine</a> at recommended intervals. They also should receive preventive antibiotics until age 5.[3929][464]&nbsp;<br />\r\n<br />\r\nAn article from eMedicine Journal provides additional&nbsp;information on treatment for pyruvate kinase deficiency at the following link. You may need to register to view the article, but registration is free.<br />\r\n<a href=\"http://emedicine.medscape.com/article/125096-treatment#showall\" target=\"_blank\">http://emedicine.medscape.com/article/125096-treatment#showall</a>","dateModified":"2011-07-18T11:47:00","resourceClassificationName":"Treatment","references":[{"referenceId":464,"authors":"Haldeman-Englert C","articleTitle":"Pyruvate kinase deficiency","bookWebsiteJournalTitle":"MedlinePlus Encyclopedia","date":"2/3/2014","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001197.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3929,"authors":"","articleTitle":"Pyruvate Kinase Deficiency","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2005","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/465/viewAbstract","dateAccessed":"2011-07-18T00:00:00"}]},{"questionId":1528,"questionText":"What is the prognosis for&nbsp;individuals with pyruvate kinase deficiency?","answerText":"The prognosis varies. Some people may have few or no symtpoms, while others have severe symtpoms. People who have mild to moderate forms of pyruvate kinase deficiency tend to do very well long term.&nbsp; People with more severe forms of the disease are mostly symptomatic during early childhood.&nbsp;Following early childhood, the condition is much better tolerated.[472]&nbsp;Some people may experience complications such as&nbsp;gallstones and&nbsp;stroke.&nbsp;Severe pneumococcal disease is a possible complication after splenectomy.[472][464]","dateModified":"2011-07-18T11:21:00","resourceClassificationName":"Prognosis","references":[{"referenceId":464,"authors":"Haldeman-Englert C","articleTitle":"Pyruvate kinase deficiency","bookWebsiteJournalTitle":"MedlinePlus Encyclopedia","date":"2/3/2014","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001197.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":472,"authors":"Hassan M Yaish, MD","articleTitle":"Pyruvate Kinase Deficiency","bookWebsiteJournalTitle":"Medscape","date":"April 28, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2196589-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":715,"questionText":"How common is pyruvate kinase deficiency?","answerText":"It is estimated that 1 in 20,000 people world-wide have pyruvate kinase deficiency.&nbsp; A particularly high frequecy exists among the Pennsylvania Amish, in whom the disorder can be traced to a single immigrant couple.[474][472]","dateModified":"2016-05-13T00:00:00","resourceClassificationName":"Statistics","references":[{"referenceId":472,"authors":"Hassan M Yaish, MD","articleTitle":"Pyruvate Kinase Deficiency","bookWebsiteJournalTitle":"Medscape","date":"April 28, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2196589-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":474,"authors":"","articleTitle":"","bookWebsiteJournalTitle":"Glader Bertil E. Chapter 76. Other Hereditary Red Blood Cell Disorders. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. Emery and Rimoin's: Principles and Practices of Medical Genetics. Vol 2. 5th ed. Philadelphia, PA: Churchill Livingstone; 2007: 1675. ","date":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":10851,"phenoTypeName":"Chronic hemolytic anemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5343,"phenoTypeName":"Reduced red cell pyruvate kinase level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15558,"phenoTypeName":"Reticulocytosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15416,"phenoTypeName":"Unconjugated hyperbilirubinemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9969,"phenoTypeName":"Congenital hemolytic anemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3910,"phenoTypeName":"Hydrops fetalis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10976,"phenoTypeName":"Increased serum ferritin","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10471,"phenoTypeName":"Increased serum iron","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10210,"phenoTypeName":"Prolonged neonatal jaundice","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4376,"phenoTypeName":"Anisocytosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15413,"phenoTypeName":"Elevated transferrin saturation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4083,"phenoTypeName":"Intrauterine growth retardation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5032,"phenoTypeName":"Nonimmune hydrops fetalis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9230,"phenoTypeName":"Poikilocytosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4737,"phenoTypeName":"Abnormality of the amniotic fluid","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":9345,"phenoTypeName":"Cholecystitis","percentRanges":"-"},{"phenoTypeId":9344,"phenoTypeName":"Cholelithiasis","percentRanges":"-"},{"phenoTypeId":9540,"phenoTypeName":"Increased red cell osmotic fragility","percentRanges":"-"},{"phenoTypeId":10276,"phenoTypeName":"Jaundice","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Pyruvate_kinase_deficiency"}